Stage
Other Investors | AliveAbout Nanotope
Nanotope is a regenerative medicine company that leverages a core set of technologies to address multiple therapeutic markets. Nanotope is developing a suite of products, each customized to regenerate specific tissues; including neuronal, vascular, bone, myocardial, and cartilage. The products are injectable compounds that work with surviving cells in and around the point of damage to initiate and support tissue regeneration and growth. Once regeneration is complete, the compounds are safely broken down and removed by the body. Nanotope's lead products target neuron regeneration for prevention or reversal of paralysis associated with spinal cord injury and angiogenesis for wound healing and the treatment of peripheral artery disease.n
Nanotope Headquarter Location
8025 Lamon Avenue, Suite 450
Aurora, Colorado, 60077,
United States
Expert Collections containing Nanotope
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Nanotope is included in 3 Expert Collections, including Pharma Startups.
Pharma Startups
6,549 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Neuroscience
2,144 items
Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.
Regenerative Medicine
1,708 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Nanotope Patents
Nanotope has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/16/2008 | 12/13/2011 | Tissue engineering, Biomaterials, Food additives, Polymers, Molecular biology | Grant |
Application Date | 4/16/2008 |
|---|---|
Grant Date | 12/13/2011 |
Title | |
Related Topics | Tissue engineering, Biomaterials, Food additives, Polymers, Molecular biology |
Status | Grant |